Association of the Benefit of Durvalumab Consolidation Therapy and Driver Mutation Status for Locally Advanced Non-small Lung Cancer

被引：0
|
作者：
Akazawa, Y. [1 ]
Yoshikawa, A. [1 ]
Miyamoto, S. [1 ]
Ameku, K. [1 ]
Yano, Y. [1 ]
Mori, M. [1 ]
Uchida, J. [1 ]
机构：
[1] Osaka Toneyama Med Ctr, Toyonaka, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
durvalmab; chemoradiotherapy; driver mutation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-13
引用
收藏
页码：S574 / S575
页数：2
相关论文
共 50 条
  • [21] EXAMINATION OF THE FACTORS THAT DETERMINE DURVALUMAB ADMINISTRAION IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
    Niitsu, Takayuki
    Uchida, Jyunichi
    Yanase, Takahumi
    Tanaka, Satoshi
    Kuroyama, Munenori
    Nishi, Takahisa
    Shimamoto, Shigetoshi
    Ueno, Kiyonobu
    RESPIROLOGY, 2019, 24 : 53 - 54
  • [22] Prognostic value of pneumonitis after durvalumab in locally-advanced non-small cell lung cancer
    Nishimura, Ari
    Ono, Akira
    Wakuda, Kazushige
    Kawabata, Takanori
    Yabe, Michitoshi
    Miyawaki, Taichi
    Miyawaki, Eriko
    Kodama, Hiroaki
    Nishioka, Naoya
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Omori, Shota
    Kenmostu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyuki
    Harada, Hideyuki
    Takahashi, Toshiaki
    ANNALS OF ONCOLOGY, 2021, 32 : S311 - S311
  • [23] Impact of radiation on host immune system in patients treated with chemoradiotherapy and durvalumab consolidation for unresectable locally advanced non-small cell lung cancer
    Pasquier, Corentin
    Chaltiel, Leonor
    Massabeau, Carole
    Rabeau, Audrey
    Lebas, Louisiane
    Lusque, Amelie
    Texier, Jean-Sebastien
    Moyal, Elizabeth Cohen-Jonathan
    Mazieres, Julien
    Khalifa, Jonathan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Boosting immune response with copanlisib in locally advanced unresectable non-small cell lung cancer starting durvalumab consolidation: A phase Ib study
    Hao, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S114 - S115
  • [25] Locally advanced non-small cell lung cancer
    Pulla, MP
    Sánchez, FV
    REVISTA CLINICA ESPANOLA, 2005, 205 (08): : 392 - 394
  • [26] The therapy of locally advanced non-small cell lung cancer (NSCLC) in the elderly
    Schild, S. E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S7 - S7
  • [27] Immunotherapy in locally-advanced non-small cell lung cancer: releasing the brakes on consolidation?
    Berman, Abigail T.
    Simone, Charles B., II
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 138 - 142
  • [28] Optimized local therapy for locally advanced non-small cell lung cancer
    Billiet, Charlotte
    De Ruysscher, Dirk
    JOURNAL OF THORACIC DISEASE, 2017, 9 (07) : 1783 - 1785
  • [29] Adjuvant radiotherapy for resectable locally advanced non-small cell lung cancer: Benefit or harm?
    Martin, Linda W.
    Darling, Gail E.
    Wigle, Dennis A.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 150 (06): : 1407 - 1409
  • [30] Durvalumab Adjuvant to Chemoradiation for Patients With Locally Advanced Non-Small Cell Lung Cancer: Real World Experience
    Haakensen, V. D.
    Nymoen, H. M.
    Langberg, C. W.
    Horndalsveen, H.
    Farooqi, S.
    Bjaanaes, M.
    Helland, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1045 - S1045
12345